| Authors: |
Amin R; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden., He R; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden., Gupta D; Clinical Research Center, Novum, Karolinska University Hospital, Huddinge, Sweden., Zheng W; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden., Burmakin M; Department of Medical Cell Biology, Uppsala University, Biomedical Center, Uppsala, Sweden., Mohammad DK; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden., DePierre JW; Department of Biochemistry and Biophysics, Arrhenius Laboratories for the Natural Sciences, Stockholm University, Stockholm SE-106 91, Sweden., Sadeghi B; Translational Cell Therapy Research (TCR), Department of CLINTEC, Karolinska Institutet, Stockholm, Sweden., Olauson H; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden., Wernerson A; Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, Huddinge, Sweden; Clinical Pathology and Cytology, Karolinska University Hospital, Huddinge, Sweden., El-Andaloussi S; Clinical Research Center, Novum, Karolinska University Hospital, Huddinge, Sweden., Hassan M; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden; Clinical Research Center (KFC), Karolinska University Hospital, Huddinge, Sweden., Abedi-Valugerdi M; Experimental Cancer Medicine, Clinical Research Center, Novum, Karolinska Institutet, Stockholm 141 86, Sweden. Electronic address: Manuchehr.Abedi-Valugerdi@ki.se. |
